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Abstract
Objective. The main aim of the research was to investigate the costs of dementia in Romania based on the estimated average cost of each person with 
dementia in Bucharest.
Method. This was a cross-sectional, non-population based study, with a mix of “bottom-up” and “top-down” data collection methods, which adopted 
the Cost-of-Illness approach from a broad societal perspective. The study involved 31 carers of patients with dementia in two Bucharest clinics in 
2013 and 2014: the PROMEMORIA Private Clinic and the “Sf. Luca” chronic disease hospital. Face-to-face individual interviews were conducted 
using a modified version of the Resource Utilisation in Dementia (RUD) questionnaire. The average direct and indirect costs of dementia per person 
in the study were estimated for the year 2013 and are presented for the three levels of disease severity – mild, moderate and severe. 
Results. The mean carer age was 59.3 (SD = 13.3), with 77.4% of the participants being females. The average cost (direct and indirect) of dementia 
per person in the study ranged from 53,787 RON to 67,554 RON (depending on the hourly wage used for valuation of the caregivers’ time). Con-
verted to the international dollar (I$) currency, using the purchasing power parity (PPP) of the US dollar in Romania in 2013, the average annual 
cost of dementia in the study accounted for between I$32,301 and I$40,583. The estimated total annual cost of dementia in Romania in 2013 was 
between I$9 bln and I$11 bln.
Key words: dementia, Alzheimer’s disease, caregivers, Romania, cost of illness, direct costs, indirect costs
Słowa kluczowe: demencja, choroba Alzheimera, opiekunowie, Rumunia, koszt choroby, koszty bezpośrednie, koszty pośrednie
Przygotowanie i edycja anglojęzycznych wersji publikacji finansowane w ramach umowy 914/P-DUN/2016 
ze środków Ministra Nauki i Szkolnictwa Wyższego przeznaczonych na działalność upowszechniającą naukę.
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Introduction
1. Background to Dementia
1.1. Dementia – definition and diagnosis
Dementia has been described as an “umbrella term” 
[1], which encompasses as many as 100 different di-
agnoses which, in certain key aspects, are more or less 
similar [2]. Usually, dementia presents itself as distur-
bance in specific and general brain functions may in-
clude memory, reasoning, orientation, comprehension, 
calculation, learning capacity, language and judgement 
[3], over a sustained period of time and is characterised 
by a progressive decline. Many researchers today agree 
that dementia is best described as a “syndrome” [1, 3–6]. 
Bayles and Tomoeda [7] explained that this term is used 
to denote a wide-ranging list of signs and symptoms 
that are associated with the progression of the disease. 
The most common forms of dementia are Alzheimer’s 
Disease (AD), which can be found in 50 to 60% of all 
dementia sufferers [8]. Other less common types of de-
mentia include Vascular Dementia and Dementia with 
Lewy Bodies, fronto-temporal dementia, Huntington’s 
Disease and dementia due to other rare neuroprogressive 
disorders. A common distinction presented in literature is 
that between cortical and subcortical dementia [8], with 
AD belonging to the former group. Its neurological pres-
entation features a development of plaques and tangles 
in the brain tissue, which are the main factors considered 
responsible for cell death and tissue loss [1].
However, there is still a debate around what constitute 
the valid categories of dementia and what are the true 
hallmark signs of AD [9]. This is one of the reasons that 
the diagnosis for AD is still carried out on a differential 
basis, as specialists need to account for “any other dis-
ease process that could be the cause of the observed cog-
nitive decline” [8]. It should also be noted that, despite 
similarities in the above key aspects of brain function, the 
different types of dementia have separate neuropsycho-
logical profiles, depending on the area of the brain that 
is affected [8]. Furthermore, individuals with the same 
diagnosis may present different symptoms and manifes-
tations, which is one of the reasons why the modern ap-
proaches to dementia care emphasise person-centred care 
and the individual tailoring of therapies [10].
1.2. Current global context
The European Parliament’s initiative on Alzheimer’s 
Disease and other dementias [11] recognises that the 
accumulation of conditions should not be perceived as 
a normal outcome of the process of ageing. It also states 
that societies should ensure that the best medical treat-
ment is available to patients, alongside other forms of 
care. However, during the last century there has been 
a significant change in the sociodemographic makeup 
of societies in general, marked by what is probably the 
most rapid and sustained period of population growth in 
recorded history. Coupled with increased life expectancy, 
in some places to more than 80 years, it led to an unprec-
edented estimate of 7 billion number of people globally 
that has been reached in 2011. This state of affairs poses 
specific challenges to public health workers [12]. One 
such challenge is caused by the complex needs of an in-
creasingly ageing population. 
1.3. Patterns in disease prevalence and burden
According to figures presented by the United Nations 
[13], the number of people aged 60 or over has increased 
approximately threefold between 1950 and 2000 and it 
is expected to continue growing by an even greater rate, 
to reach almost 2 billion by 2050. In 2005 24.3 million 
worldwide were living with dementia and it is expected 
that in 40 years’ time this number will have increased 
almost four fold. In the meantime, a WHO global report 
(completed in partnership with ADI) [3] has highlighted 
that 35.56 million people worldwide were then living 
with dementia and produced an even greater estimate for 
the number of people who will have dementia by 2050: 
115.38 million people aged 60 or over. The most recent 
ADI report [14] estimates that worldwide there are over 
9.9 million new cases of dementia each year, with up-
dated estimates that every year surpass the projections 
made the previous year. The total number of people with 
dementia in 2015 was estimated at 46.6 million and, at 
this rate of growth, the prediction for 2050 was increased 
to 131.5 million. 
When looking at mortality rates, one needs to bear 
in mind that dementia is usually accompanied by one or 
more somatic commorbidities. One multicentre study 
has found that most AD patients in a US population have 
at least three commorbid medical illnesses [15], which 
makes it difficult to attribute the outcomes to dementia 
alone. It is more likely that dementia and/or AD will 
count more towards “contributory” causes of death, rath-
er than towards “underlying” causes [16]. A 14-year mul-
ticentre prospective cohort study has found that people 
with dementia could expect to live, on average, 4.5 years 
after receiving a formal diagnosis [17]. The authors also 
documented the impact of other factors, such as married 
life (in which case people with dementia lived for an av-
erage of 7 years), age, gender (with males dying faster 
than women) and the effect that functional impairment 
may have on the length of survival. This finding was 
confirmed by a French community-based cohort study, 
which found the same average survival time, for a popu-
lation with a mean age at onset of 82.3 years [18]. Nev-
ertheless, in a review of published studies on this topic, 
Todd et al. [19] concluded that there is substantial hetero-
geneity between studies, with regard to their design and 
concluded: “it is clear that dementia and AD are associ-
ated with significant mortality” (p. 1109). According to 
Murray et al. [20] the distribution of Disability-Adjusted 
Life Years (DALYs) indicate that the greatest burden on 
the global population is due to Non-Communicable Dis-
eases (NCDs). AD and other dementias globally do not 
appear on top of the list for DALYs by cause, nor do they 
figure prominently on the list for Years of Life Lost. This 
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is because most people who die due to dementia have 
already passed, or are very near their threshold of life 
expectancy. Nevertheless, it is important to note, that, af-
ter broad consultations for the Global Burden of Disease 
report, the global community agreed to award a higher 
disability weighting for dementia: 0.67, one of the most 
severe ratings, with the exception of severe develop-
mental disorders [14]. This means that every year lived 
with dementia entails the loss of two thirds of the year 
(causes 0.67 DALYs). According to the latest GBD study 
methodology in Romania [21] the burden of AD and 
other dementias on society of Romania has dramatically 
increased. Compared to the year 1990, the burden of AD 
and other dementias expressed in DALYs per 100,000 of 
the population in 2015 had increased by 82.82% (mov-
ing from 26th to 12th in the ranking of the top causes of 
disease burden in Romania) [21].
1.4. Diagnosis and resource utilisation challenges
In time, as more research has explored the progres-
sion of the syndrome, some organisations have seen 
increasing benefits in breaking down the three broad 
stages of disease progression into several, more specific 
stages (e.g., [22]). More recently, an entirely new diag-
nostic category has been added, namely Mild Cognitive 
Impairment (MCI), the purpose of which is to identify 
people with an increased risk of developing a form of 
dementia in the future [6]. It is defined as “Cognitive de-
cline greater than expected for an individual’s age and 
education level, but which does not notably interfere with 
the activities of daily life” [23]. Such a diagnostic tool 
is believed to have real value in early identification and 
secondary prevention (p. 1262), although it should be 
mentioned that, according to [24], the early recognition 
of dementia poses certain “risks” to patients, those close 
to them, and even social and/or medical services. For this 
reason, an increased sensitivity in the detection of early 
signs of dementia in primary care needs to be accompa-
nied by capacity building to manage the extra challenges 
caused by the increasing number of people with a formal 
diagnosis (A. Bayer, personal communication, the 26th of 
March, 2014). 
While a project that would ensure most people with 
dementia receive a diagnosis might prove to be very 
costly in terms of resources, it is clear that the current 
situation is also rather costly for health and social ser-
vices. Ultimely diagnosis is acknowledged to be a prob-
lem throughout Europe, including in the more developed 
health care systems of the Western countries [25, 26]. 
Some of the reasons invoked for this state of affairs 
are: social stigma, professionals’ disbelief regarding 
the capacity to offer help that makes a difference in the 
patients’ state [26] and the large demand on the human 
and financial resources needed to implement a Primary 
Care screening tool [27]. It may be that a high proportion 
of people with dementia are put in a position to receive 
a formal diagnosis only after they have been admitted 
into emergency services [28]. Naturally, this combination 
usually has the effect of prolonging the patient’s stay in 
hospital, which can only bring unnecessary additional 
cost and distress to those who find it difficult to adapt to 
this environment. Thus, Lyketsos et al. [29] have shown 
that the mean length of stay in a general hospital for peo-
ple with dementia was, on average, more than double 
that of people without dementia. From a perspective of 
service use, additional resources will be needed to man-
age cases of people with dementia needing emergency 
treatment [30]. 
1.5. Dementia on the public health agenda
The historical trajectory of the public’s awareness 
of dementia (with particular reference to AD), resem-
bles an exponential, rather than a linear function. Two 
decades ago, it is unlikely that most people knew about 
the clinical diagnosis of AD and its implications. How-
ever, relatively quickly, cases of dementia became more 
visible through the media reporting cases, such as: Iris 
Murdoch, Terry Pratchett, as well as people from the po-
litical sphere, such as the former prime-minister of Great 
Britain, Margaret Thatcher and the former president of 
the United States, Ronald Reagan. The latter’s diagno-
sis, received soon after stepping down from office, has 
raised issues about the capability of world leaders to 
retain their role in case of early symptomatology of the 
syndrome [31]. Academically, there has been a massive 
increase in research findings and, while it is agreed that 
not much can be done at present regarding genetic risk 
factors and effective treatment in the case of diagnosis, 
there are some positive insights gained from the study of 
environmental factors in the development of the disease 
[32]. The most promising line of research is focused on 
vascular dementia and, according to results from a major 
study, antihypertensive treatment (treating 1000 elderly 
people with systolic hypertension could prevent as many 
as 19 new cases of dementia in the next five years). Ad-
ditionally, other strategies for prevention explored by sci-
entists include: encouraging cognitive activity, physical 
exercise, social engagement, a healthy diet and recogni-
tion of depressive symptomatology [32]. 
Individual countries from the developed world also 
took national, political initiatives to “fight back” (in the 
words of prime-minister David Cameron – [33]) against 
the rising wave of dementia. This was followed by supra-
national joint agreements (e.g. [11]), the declaration of 
dementia as a public health priority on the agenda of 
WHO [3] and finally the G8 summit, hosted in London 
at the end of 2013, focused exclusively on dementia. 
Such recognition should also be taken to mean, apart 
from the fact that world leaders are genuinely interested 
in improving the lives of the elderly, that dementia has 
an economic cost. As stated previously, if inappropriate 
action (or none whatsoever) is taken, the cost of demen-
tia is predicted to rise with devastating consequences for 
health systems in terms of service utilisation. 
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2. Cost of Illness study – a useful approach to assess burden of 
disease in monetary units
2.1. Cost of Illness studies: their value and relevance
Cost-of-Illness (CoI) studies are a form of economic 
analyses expressing in monetary units the burden of dis-
ease to a society. The aims of the authors of such stud-
ies are, according to Byford et al. [34], “to identify and 
measure all the costs of a particular disease, including the 
direct, indirect and intangible aspects” (p. 869). From an 
economic perspective, the method used to evaluate indi-
rect costs (such as those valuing the time of informal car-
ers) are not straightforward. As there is plenty of heteroge-
neity regarding the methods employed, CoI studies have 
become fairly controversial regarding the extent to which 
they should be used for decision-making purposes [35]. 
Some researchers recognise CoI studies as being useful 
for estimating the amount a society spends on a disease 
(and thereby calculate the how much could be saved if the 
particular disease could be eliminated) as well as breaking 
down the total costs into sectors based on the source of the 
contribution [36]. Others, such as Currie et al. [37] stress 
that, while CoI studies have “political” value in drawing 
general attention to a particular issue or disease, they are 
not fit for use in decision-making and academic research. 
Furthermore, Byford et al. [34] conclude that CoI research 
adds “little to the creation of an efficient healthcare sys-
tem” (p. 1519) and that more focus should be placed on 
cost-effectiveness analyses and other economic evalua-
tions. Other experts seem to be less trenchant on this mat-
ter, with McDaid [38] stating that, despite inherent issues 
in CoI studies with regards to valuing informal carer time, 
it is very important for academics to increase efforts to 
improve the accuracy of evaluating the time of informal 
carers. His paper lists a few reasons why this would be 
relevant in the present socio-economic context, including 
recognising that what is perceived today as a “free re-
source” by the state might need to be provided as a formal 
service in the future.
In the USA, CoI studies estimates are already being 
used by Congress as one measure of allocating research 
dollars among the National Institutes of Health specifi-
cally in: defining a problem economically, justifying 
intervention programs, offering a basis and a theoreti-
cal framework for future policy and planning interven-
tions, as well as for further and better quality research 
[39]. The fact that some of the methods used for CoI 
do not provide satisfactory accurate results should not 
prompt one to generalise these misgivings onto the en-
tire category. A careful analysis of key aspects, such as 
the perspective taken by the authors, the exact methods 
used to estimate and value specific resources used, as 
well as the aims of the research may help to establish 
the value of a particular study. In their review of CoI 
studies on dementia, Costa et al. [40] stressed that clear 
descriptions in the methodology section are the key to 
a better understanding of the variation in reported costs. 
The latter argue that CoI studies can serve as a basis for 
future projections of expenses linked to a particular dis-
ease and may be able to influence managerial decisions 
to control the costs of AD. 
2.2. Cost of Illness studies – an empirical framework
As mentioned earlier, the framework of CoI studies 
encompasses a wide variety of costs which are generally 
divided into two categories: direct and indirect. Direct 
medical costs include all forms of expenditure that derive 
from living with a particular illness, such as: prevention, 
detection, treatment, rehabilitation, research, training and 
annual costs of capital investment in medical facilities 
[41]. Additionally, this category includes non-medical 
costs, such as transport fees, social care costs – formal 
services provided outside of the medical care system, in-
cluding community services such as home care, food sup-
ply and transport, and residential or nursing home care 
[42, 43]. The other large category included in the CoI 
studies, namely indirect costs (productivity costs), repre-
sents lost economic productivity due to death (mortality 
costs) or lost or impaired ability to work or to engage 
in leisure activities due to illness (morbidity costs) [44]. 
Morbidity costs are comprised of the economic conse-
quences of reduced productivity during short-term and 
long-term absence from work (absenteeism) or produc-
tivity costs without absence (presenteeism) [45]. 
In practice, any cost that does not result in direct use 
of resources, but that leads to resource loss due to disease 
may be considered as indirect [39]. There are several 
methods currently employed in literature to value time 
lost due to the disease. 
The human-capital approach is the most frequently 
used method [45–47]. It assumes that the productivity of 
a person may be valued according to his or her salary, and 
essentially measures the productivity lost by employers 
by the absence of people who take days off work for rea-
sons of illness or caring responsibilities [48]. However, 
this method has not been without its critics who, interest-
ingly, have argued that the human capital approach may 
both over-estimate [45] and under-estimate the indirect 
costs [39]. The former argue that the potential, rather than 
the real loss is measured, while the latter claim that the 
approach underestimates the value of children and the 
elderly. Another more recently developed approach to es-
timating the indirect costs is the “friction cost” method. 
It takes into consideration that short-term absence from 
work may be dealt with by the assignment of uncovered 
tasks to other employees while long-term absence might 
be overcome by hiring a new worker [45]. What it es-
sentially does, is to limit the time frame for which the 
costs of absence are taken into account. Despite the theo-
retical indecisiveness, practical research can employ both 
methods, and then present the results with a sensitivity 
analysis. 
Two main approaches may be used to collect data re-
garding the use of resources: (i) The bottom-up approach 
and (ii) The top-down method. The former implies that 
researchers collect data from individuals, usually using 
questionnaires, while the latter relies on studies that draw 
data from official publications and government releases 
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[40]. In practice, research that aims to make a compre-
hensive estimate of the use of resources will tend to use 
a mix of both approaches. Nowadays the questionnaires 
used in the bottom-up approach tend to be disease-spe-
cific and to tap into both direct and indirect costs. There 
are several instruments designed to evaluate the costs 
related to caring for dementia patients in particular, of 
which the most prominent are: the Caregiver Activity 
Survey (CAS) [49]), the Caregiver, Time Survey (CATS) 
[50] and the Resource Utilisation in Dementia (RUD) 
[51, 52]. For the purposes of the present study, the RUD 
instrument, whose authors claim it to be the most popular 
tool of its kind [52] was selected. The constant efforts 
invested by its creators to improve and adapt it have led 
to the development of versions fit for use in clinical set-
tings (see [52] for further details), in community settings 
[53] or, more recently, in a global setting [51]. The ques-
tionnaire essentially asks carers to self-report their use 
of resources needed to care for their patient with demen-
tia. This has been shown by Wimo and Nordberg [54] to 
present a close correlation with register data regarding 
hospital care, family physician and district nurse visits. 
In their conclusion, the authors recommended that inter-
views based on the RUD format may “serve as a valid 
and reliable substitute for observations”.
2.3. Global research on the costs of dementia
Mirroring the unexpected growth and constant re-
evaluation of the prevalence of dementia in the global 
population, the estimates for the economic costs of de-
mentia have increased significantly with time [53, 55]. 
The latest estimate of the worldwide economic impact for 
dementia is for 2015 and it indicates a total cost of US$ 
818 billion [14]. This is an increase of 35.4% from the 
2010 estimate of US$ 604 billion. The dramatic change 
in the estimated cost in the last five years arises mainly 
from the fact that the 2010 prevalence values were not 
as accurate as those for 2015. In 2010 70% of the global 
costs occurred in Western Europe and North America 
[51]. Although both studies show that the most developed 
countries (e.g., G7, G20) incur a larger share of the total 
cost than all the other countries combined, the latest fig-
ures reveal that the greatest relative increases occurred in 
the African and East Asia regions, mirroring their higher 
rate of economic/social development. One of the reasons 
why high-income countries have a much higher cost of 
dementia than low-income or middle-income countries 
(apart from the obvious fact that living wages and, as 
a result, prices are generally higher) is that the costs of 
social care included in the direct non-medical costs cat-
egory account for a greater percentage of the total costs. 
This is because care, especially in the West and North 
of Europe, is less frequently undertaken by the family 
or friends of patients, but more by professional services, 
whereas informal care, which gives a lower estimate of 
costs, remains the norm in other countries, including 
those from Eastern and Southern Europe [56]. 
In a European study of the costs of brain disorders, 
Olsen et al. (2011) found that dementia, in terms of di-
rect non-medical costs, was the most expensive disease 
presented in their study. This category of expenditures 
includes all costs directly related to the disease that may 
be required for social services, special accommodation 
and/or informal care, excluding health care costs (includ-
ing pharmaceutical products) related to treatment of the 
disease (p. 722). The total cost of dementia in the EU27 
was estimated by Wimo et al. [56] to be approximately 
€160 billion, with €22,000 per year required in average 
for each demented person, of which informal care ac-
counted for 56% of the total cost. European estimates can 
be as high as £25,472 per year per person in the UK with 
dementia [25] converted to 2013 nternational dollars (I$) 
accounting for I$42,956.5 (authors’ own conversion).
A 2014 dementia CoI study in France was undertaken 
by following a methodology similar to that used in our 
own study [57]. 57 patients and their carers were inter-
viewed using a modified version of the RUD question-
naire, with the explicit aim of taking both formal and 
informal care into consideration for the final estimate of 
cost – a feature less frequently seen in CoI literature. The 
monthly average total cost per person varied between 
€2,450 (converted to the 2013 international dollars ac-
counted for I$2,952; annually I$35,424) when using the 
proxy good method, and €3,102 (I$3,737.6; annually 
I$44,851) when using the opportunity cost method. The 
authors argued that the figures indicate that the current 
French allocation will be unable to meet all costs in-
volved in caring for patients with dementia. As a result 
there are clear policy implications, with decision-makers 
having to balance spending more on formal care, or on 
programmes dedicated to developing a patient’s relatives 
as informal carers.
While it is beyond doubt that there are clear cost dif-
ferences between the West and East of Europe, the use of 
different methodology and currencies make international 
comparisons and extrapolations difficult and untenable. 
Furthermore, beyond methodological difficulties, the va-
lidity of European estimates of the cost of illness is clearly 
biased towards a Western European database, with most 
studies concentrated in countries such as the UK, France, 
Belgium, Ireland, the Nordic Countries, Germany, Italy 
and Spain [56], with few studies in Eastern Europe. To 
our knowledge there have been only two cost-of-illness 
studies carried out in the East of Europe: one in Hungary 
[58], and one in Turkey [59], but the latter may not be 
particularly representative of Eastern Europe. Indeed, the 
literature on the burden of dementia generally outlines 
the key priorities for the future, including the need for 
more research to be undertaken in Eastern Europe ([14], 
p. 13; [56], p. 830).
3. Background to the Romanian context
3.1. Romania – socio-political and economic context
Romanians can be categorised as a nation formerly 
operating with a socialist economy. Its public system 
still pays tribute to its previous communist government, 
branded, following the Second World War, as one of the 
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harshest totalitarian regimes in Eastern Europe [60]. 
Understanding the historical transition of the Romanian 
state, from exclusively state-owned public services be-
fore the December 1989 revolution, to the transition to 
a market-based economy post-1990 is essential in fram-
ing the context for healthcare or the system of social 
care. These have not only inherited a heavily centralised 
structure, with most funds directed towards tertiary/hos-
pital care but additionally, they have a low priority on 
the policy agenda [61]. Furthermore, in an evaluation 
of the Romanian social care system at the time of the 
country’s integration into the EU, Zaman [62] described 
it as institutionally “fragmented”, without “clear deline-
ation of responsibilities” and inadequately decentralised 
(p. 1). In terms of the proportion of the older population 
that live in poverty, Romania has an average position, 
with an estimate of approximately 20% at the time of 
the accession to the EU [63]. Nevertheless, it should 
be taken into account that an unexplored, but consider-
able, social issue in Romania is the degree to which the 
elderly can afford to buy the required medication and/
or to lead a healthy lifestyle. Indeed, Vintila et al. [64] 
(p. 84) reported that many old people from Romania 
invoke lack of funds as the main reason for not imple-
menting the rules for a healthy lifestyle, rather than ig-
norance. Knowing more about the needs and resources 
available to this population is critical for designing 
better and more effective services, especially for those 
facing chronic diseases.
The Romanian population has been decreasing stead-
ily and steeply since the 1990s, with a reduction of ap-
proximately 1,100,000 people between 1992 and 2002 
[65, 66] and by a further 1,800,000 between 2002 and 
2012 (Eurostat estimates [67]), resulting in an estimated 
total population of approximately 20,000,000 in 2013, 
due mainly to increased rates of migration (after acces-
sion to the EU) and to low birth rates [67]. This has trans-
lated into a total decrease in population of almost 3 mil-
lion in just 20 years. The estimates grouped by categories 
of age, show that the only group that increased rather 
than decreased is that of people older than 60 [68] (p. 10). 
Indeed, some projections [69] predict that by 2060 Ro-
mania will have become the country worst affected by an 
ageing population, with an effective economic old-age 
dependency ratio that is expected to exceed 100%1. This 
makes Romania a good example of a middle-income, de-
veloping country, since this group is expected to face the 
greatest increase in dementia cases in its population in 
the next 50 years [70, 71]. 
With a Gross Domestic Product (GDP) per capita es-
timated at I$21,403 in 2015 [72], Romania remains one 
of the EU countries that allocates the smallest share of 
its (GDP) to healthcare and health-related services (5.6% 
according to the World Bank [73] (Table I). It has moved 
towards a social insurance system based on the Bismarck 
model, especially since the National Health Insurance 
House was established by the Social Health Insurance 
law no.145/1997. In 2012, approximately 75% of the 
total health budget was met by social health insurance 
[74]. Nevertheless, according to a few academic articles 
discussing this topic, the healthcare system in Romania 
remains fraught with issues such as resource mismanage-
ment, corruption, the migration of large numbers of peo-
ple, or unequal distribution of funds [75].
3.2. Dementia in Romania: analysing available resources
The state of Romanian awareness and action regard-
ing Alzheimer’s and other dementias today is still at 
a basic level. At the moment there are no epidemiologi-
cal studies to investigate dementia in Romania and the 
awareness of the disease and its implications are at a low 
level nationally. This has been suggested as a reason 
for the late management of cases with dementia and, as 
a result, for the larger number of comorbidities found in 
Table I. Total health expenditures % of GDP in EU countries, 
year 2014






























Source: World Bank, Health expenditure, total (% of GDP), 
http://data.worldbank.org/indicator/SH.XPD.TOTL.ZS, 2014; 
accessed: 15.10.2016 [73].
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the Romanian population [76]. Nationally, research dedi-
cated to the syndrome has increased in recent years, but it 
focuses more on the biological and clinical approaches to 
dementia, with very few studies documenting the social, 
psychological and/or economic dimensions.
There are two main memory clinics in Bucharest: 
the Memory Centre at the Dr. Obregia Hospital and the 
Centre for Diagnosis and Treatment of Memory-related 
Diseases. The former, the first such clinic opened in 
Romania, was established in 2000, as a partnership be-
tween the Romanian Alzheimer’s Society (RAS) and 
the leading psychiatry hospital in Bucharest: Prof. Dr. 
Alexandru Obregia [77]. The clinics are meant to act pri-
marily as ambulatory centres, with accurate diagnostic, 
patient monitoring and individualised treatment schemes 
being among their core service aims [77, 78]. In 2009 
the PROMEMORIA private clinic was established for 
similar purposes [79]. The development and provision of 
services for dementia in Romania is still underdeveloped 
and lacks the multidisciplinary approach present in many 
Western countries. Additionally, the training of medical 
staff, support and protection of patients, as well as carers, 
are all insufficient or even non-existent. The effects of 
the financial crisis have been visible, especially on the 
provision of resources for public services: the Memory 
Clinic at the Dr. Obregia hospital (the first of its kind to 
be established in Romania) has had to face several set-
backs, including the lack of financial support to manage 
and sustain its office. The lack of political commitment to 
the issue of dementia was outlined at the 2014 National 
Dementia Conference by the President of the RAS, Prof. 
Dr. Catalina Tudose [80]. 
At this event the RAS released the first National 
Strategy and a Plan of Action for dementia [81], which 
aimed to address the lack of coherence in the political 
objectives. Unfortunately, this document has not been 
assimilated politically, unlike the case in other coun-
tries where, sometimes with the explicit backing of the 
leading politicians (e.g. The UK National Dementia 
Challenge was backed by the former Prime-Minister, 
David Cameron) and the French strategy for dementia 
2008–2012 promoted by the former president, Nikolas 
Sarkozy [82, 83] . Nevertheless, the article by the RAS 
describes the Romanian institutional framework for 
care and medical services for dementia as “incipient” 
(p. 2), with an insufficiently-developed care system for 
patients and their carers. At the same time, financial 
constraints, as well as a dearth of clinical and epidemio-
logical data and the absence of a National Registry are 
seen as key barriers to future developments in this field. 
Estimating that 270,000 people suffer from dementia in 
Romania, of whom only 35,000 have received a formal 
diagnosis, the strategy calls for a multidisciplinary ap-
proach, involving partnerships between key public and 
private institutions in order to improve an early access 
to diagnosis and treatment. The main aims included in 
the document, involve raising public awareness of the 
syndrome, creating a national patient database, increas-
ing the amount of research on dementia and de-stigma-
tising patients. 
3.3. Aims and objectives of the study
The aim of the research was to investigate the cost 
of dementia for individual budgets (both for health and 
social care), the Romanian social health insurance sys-
tem and the broader, societal costs related to the income 
lost because of the care provided by caregivers to pa-
tients. We believe that this project can be a political tool 
and that it should be part of a broader increase in the 
research and planning, needed to push dementia onto 
the public agenda. It is hoped that the results and meth-
odology used will provide a resource for the relevant 
authorities that would increase their awareness of the 
socio-economic impact of dementia in Romania, using 
a national sample, rather than estimates based on the 
findings from Western populations. Obviously, the re-
sults of this research project cannot offer a definitive 
estimate of the cost of dementia in Romania, principally 
because of the small sample and the patients not being 
used to participating in research. There have been sever-
al instances during this research, when participants have 
avoided giving particular kinds of information. This is 
why we encourage the project to be viewed as a pilot 
intended to refine the national approach to costing de-
mentia. As stated earlier, to improve global estimates 
another CoI study in a Eastern European country is very 
necessary and is a resource requested by international 
researchers. 
Methods
The present CoI study assessed the national burden 
of dementia from a societal perspective. It analysed 
costs at both individual and public level (represented in 
Romania by the single, National Health Insurance House 
– NHIH) and it additionally investigated the cost of the 
hours dedicated by informal carers to patients with the 
disease. Several data sources were used to achieve this: 
official government statistics, official reports on demen-
tia (including those released by third sector organisa-
tions), individual data and clinical records. As a result, 
our approach can be described as both top-down and 
bottom-up, with regard to its approach to costing. Ad-
ditionally, we used a prevalence-based design [84] so 
that we were focusing only on an estimate of the annual 
cost of dementia for 2013, with prospective sampling of 
the caregiving population (patients were not included in 
the individual interviews, because of logistic difficulties 
and the expense involved).
1. Participants
We recruited 31 participants from two partner institu-
tions in Bucharest: 12 participants from the “Sf. Luca” 
Hospital of Chronic Diseases and from the PROMEMO-
RIA centre for diagnosis and treatment. The former is 
a public hospital, while the latter is a private clinic which 
specialises in screening, diagnosis, disease monitoring 
and long-term personalised treatment for cerebral age-
ing. All participants were carers of patients with vari-
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ous forms of dementia. Most questionnaires [24] were 
completed by female respondents. In the current sample 
the population of people living in a care home is grossly 
underrepresented (only 1 respondent stated that the cared 
for patient resided in a care institution). This means that 
the present analysis will not establish and investigate the 
differences between the costs for patients living at home 
or in an alternative form of accommodation. It should be 
stressed that the present study focuses mainly on carers 
and the resources needed to care for dementia patients. 
However, data on the medical care of patients with de-
mentia were also collected.
2. Questionnaire
The RUD questionnaire was translated and adapted 
to better evaluate the costs within the Romanian health-
care system (See Appendix). The Romanian version was 
obtained by a process of back translation, with the help 
of two Psychology Masters students (see Acknowledge-
ments for more details), with an input from one of our 
collaborating doctors. As stated earlier, we have inserted 
some additional questions: 1. The diagnosis received by 
the patient, which has been completed together with the 
doctor managing the patient’s illness (number A1.1.5); 
2. The distance between the current residence of the carer 
and that of the patient (question A1.1.7); 3. The means of 
transportation used to reach the patient’s residence (ques-
tion A1.1.8); 4. The number of other carers looking after 
the patient (number A1.1.9); 5. The number of people 
living with the carer (question A1.1.11); 6. The carer’s 
household income (question A1.1.12); 7. Recent changes 
in the patient’s accommodation (altering section A2.1); 
8. The services needed, but not received by the patient: 
For this purpose, we added, at the beginning of section 
A2.2 a question about the number of times the patient 
had been referred to a hospital in the past year, followed 
by question 2, which asks whether the patient was actu-
ally hospitalised after each referral, and then question 3, 
which asks for the reason that prevented the patient from 
going to the hospital; 9. Whether the patient has visited 
public or private practices (questions A2.2.5 and A2.2.7); 
10. Emergency care (question A2.2.8); and 11. Use of 
medication (question A2.2.10).
We excluded from our version the sections on health 
care and medication use by the caregiver, included by 
the original RUD [52] and we modified some of the time 
frames proposed by the original authors: (e.g. when ask-
ing carers about the number of patient hospitalisations, 
a 12-month, period was considered, instead of 30 days; 
the question about outpatient health specialist visits was 
applied for a period of 30 days, as used in the original 
version and the emergency services use was monitored 
for the last 90 days, instead of 30 days. The table describ-
ing the number of nights spent in a specific hospital ward 
(question A2.2.4) has been expanded to include transport 
costs, medical and non-medical out-of-pocket payments 
and, similarly the table for outpatient visits, has two col-
umns added for out-of-pocket expenditure and transport 
costs (question A2.2.6. of the questionnaire).
3. Procedure
Between December, 2013 and March, 2014 a cross-
sectional questionnaire survey of 31 carers of patients 
with dementia in Bucharest was conducted in the two 
health care centres referred to earlier. The questionnaires 
were completed by carers during visits to the clinic (either 
for regular monitoring of the patient, or for the receipt 
of the monthly drug prescription) with the assistance of 
either, a member of staff, or the leading researcher. The 
carers were used as proxy informants regarding the pa-
tients’ situation. Because of the characteristics presented, 
the survey conducted is a non-population, cross-sectional 
study, employing the modified RUD questionnaire de-
scribed above. The benefit of this questionnaire is that it 
enables us to divide the time allocated by carers into three 
categories: Personal Activities of Daily Living (PADL), 
Instrumental Activities of Daily Living (IADL) [85] and 
the time dedicated to supervision [54]. The first two are 
easier to conceptualise, with the former referring to basic 
activities, such as washing, eating and getting dressed, 
while the latter (IADL) captures more complex tasks, not 
needed for fundamental functioning, such as shopping, 
cooking, managing finances, using a telephone to com-
municate, doing the laundry and travelling independently 
in public. The category “Supervision” describes any car-
ing activity that does not support a clear daily function, 
but which rather monitors a patient’s behaviour and pre-
vents accidents. For the purposes of the research, we have 
taken into consideration the carer’s reported hours spent 
undertaking PADL and IADL together (See Appendix, 
Section A1.2, Questions 2.a) to 3.b)) when calculating 
the indirect costs associated with the syndrome. Prior to 
undertaking the research project, an ethical approval was 
obtained from the Ethics Committee of the “Sf. Luca” 
Hospital. 
4. Calculating costs
Costs were divided into two categories: direct 
and indirect, with the former being split into medical 
and non-medical costs. Services related to inpatient and 
outpatient hospital care, emergency services, medication 
and diagnostic services were included in the medical 
category, while the latter included non-medical services 
costs, transportation costs, additional products and ser-
vices needed during hospitalisation and the caregiving 
cost. When analysing direct medical costs in particular, 
we looked at costs covered by the public payer (in our 
case, the NHIH) and the amount paid out-of-pocket 
(OOP) by patients. All costs were for 2013. For outpa-
tient visits, the official tariff per visit by specialisation, 
as set in the most recent government order concerning 
methodological standards for implementing the National 
Framework Contract, was used. The NFC regulates the 
prices and criteria of medical practices contracted for 
by the NHIH [86]. These prices were multiplied by the 
average number of outpatient visits from all participants 
to estimate monthly and yearly average costs by spe-
cialisation. When calculating OOP payments, we gener-
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ally used values reported by carers, but where they were 
unavailable, the number of times services were utilised 
by dementia patients was multiplied by the value of the 
newly introduced co-payment rate. It should be noted that 
these rates vary, as each hospital is entitled to set its own 
co-payment rate, estimated at 10 RON per visit, with the 
exception of GP visits, estimated at 5 RON per visit, and 
physiotherapy sessions (which were calculated by divid-
ing the cost of a therapeutic intervention (50 RON) by 
10, the average number of sessions included in an inter-
vention). Theoretically, these are the only payments a pa-
tient should make when accessing these forms of medi-
cal services. Inpatient costs were calculated in a similar 
fashion, using the cost of one day of hospitalisation for 
different medical specialisations and multiplying this by 
the average number of days spent in each ward by the 
participants. The OOP was calculated by adding the fixed 
co-payment amount (multiplied by the number of hospi-
talisations, since the co-payment rate set for hospitalisa-
tion is a fixed sum to be paid at the end of the inpatient 
stay) to the additional medical costs reported by carers in 
the questionnaire. 
Additionally, under the same category (direct medi-
cal costs), we also included the cost of medicines. The 
monthly use of medication has been, with few exceptions, 
thoroughly documented by the collaborating doctors and 
information regarding the costs and the amount covered 
by the NHIH were taken from the official “nomencla-
ture” issued by the National Medicine Agency (NMA) in 
[87]. Since information was not always provided for the 
particular coverage scheme that was applied to each indi-
vidual patient, we assumed the regular patient coverage 
by the NHIH applied when the percentage of medication 
cost covered was not indicated by the doctor. There was 
no cap on the total amount of medicines one could report, 
but generally, with only one exception, participants men-
tioned 10 or less prescribed medicines that were currently 
being used by patients. Each patient had their individual 
medical costs calculated for OOP, NHIH reimbursement 
and overall costs and these sums were multiplied by 12, 
assuming that the medication was used throughout the 
year. We excluded medication that was likely to be pre-
scribed on a temporary basis (such as vitamins, or sleep-
ing pills), although aspirin was included, because to its 
prolonged use to prevent cardiovascular complications. 
Finally, the individual yearly totals were added and di-
vided by the number of participants, to obtain the an-
nual average per patient. To obtain national costs, this 
value, as with other costs was multiplied by the estimated 
number of people in Romania living with dementia. If 
medicines could not be found within the main NHIH da-
tabase, the price was derived from at least 2 different on-
line pharmacies and the average value used. Apart from 
the cost of medication, the medical expenses included 
diagnostic services, taken from the nationally approved 
Official Guide for Diagnosis and Treatment of Dementia, 
issued by the Romanian Neurology Society (RNS) and 
the RAS, 2007 and costed on a fixed, individual level us-
ing the aforementioned Government document [86]. The 
diagnostic services are fully funded by the NHIH. Ad-
ditionally, we evaluated the use of Emergency Services 
separately, using the number of cases reported by carers 
and multiplying that by the cost of an 8-hour stay in one 
of the Emergency Departments in Bucharest [88].
As stated above, the other category calculated as 
a direct cost included non-medical services. The sec-
tion covering non-medical expenses which were in-
curred during a hospital stay (usually products such as 
disposable diapers, tissues or bed sheets) per year was 
estimated using the carer’s reported costs. The transport 
costs were calculated using carers’ estimates of the cost 
involved in a one-way trip to the hospital/clinic, either 
for outpatient, or for inpatient care (assuming equal 
transport costs for both directions). When cost data 
was missing, the number of visits to the hospital was 
multiplied by twice the cost of bus ticket in Bucharest 
(1.3 RON) (a two-way trip being assumed). We also 
calculated the cost of other services shown in the table 
for question 9 from section A2.2 of the RUD question-
naire, multiplying the costs per visit indicated by carers, 
by the number of visits per 30 days, and then by 12 to 
obtain annual estimates. Finally, the annual direct cost 
of caring was calculated using the carer’s response to 
question 4 from section A1.3 of the questionnaire and 
multiplying the number of hours spent formally caring 
for the patient by a carer’s hourly wage in Bucharest. 
Where carers did not earn a formal salary we consid-
ered the time spent tending to the patient, which meant 
adding the values in questions 2a) and 3a) from section 
A1.2 of the questionnaire, i.e. IADL+PADL), and mul-
tiplying it by the number of days during the last 30 days 
that this had been done. No cap, except for the obvious 
24 hours cap, was placed on the total number of hours 
of patient care per day. Additionally, we considered at 
the personal contribution of the particular carer (i.e. the 
percentage of care time covered by him or her – see 
question A1.1.10) and used that to compute the total 
caring time required by the patient. The final estimate 
was obtained by multiplying the hours spent caring per 
month by the minimum hourly salary, and then by 12, in 
order to obtain an annual amount.
5. Valuing carers’ time 
The indirect costs are comprised of the cost of the 
carer’s time lost while caring for the patient (which var-
ied due to the range of carers’ salaries), the cost of the 
patient’s time lost accessing care (valued at the mini-
mum wage) and the carer’s time of work (permanent 
reduction of working hours or unemployment) under-
taking caring responsibilities (valued at the average 
wage). In valuing informal caregiver time, Wimo et al. 
[51, 55] recommend the use of the proxy good method 
(also called the replacement/market cost method). This 
is considered by some to be a “non-marketed use of 
time” [89] (p. 38), as it usually values time spent car-
egiving using the market price of a close substitute (e.g. 
a paid caregiver). According to Van den Berg et al. [90], 
at a conceptual level, it focuses on the output of pro-
duction and attempts to find a market equivalent to an 
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informal service (such as caregiving) and use the market 
price in the final analysis. However, there are other ap-
proaches that could be considered, for instance, when 
performing a sensitivity analysis, most notably the op-
portunity cost. This values the opportunity foregone by 
a carers as a result of fulfilling their duties towards the 
dementia patients, which could include working and 
earning a salary [40]. In our research we have tried to 
vary the value placed on caregivers’ time, using a sen-
sitivity analysis. Thus, we have used three different ap-
proaches: 1. The hourly salary of a carer in Bucharest 
(as this figure is not officially available, our estimate 
is based on the information given by the relatives of 
dementia patients who employ a carer for the patient); 
2. The average hourly salary in Romania (available 
from the National Statistics Institute – NSI website); 
3. The minimum hourly salary in Romania (also known 
as the salary for unqualified work), based on estimates 
delivered by the NSI. The amount of time dedicated to 
the care of dementia patients was estimated on the basis 
of the sum of the two types of daily caregiving activities 
PADL and IADL. It should be reiterated, that, while the 
study done in Hungary [58] placed a cap of 8 on the 
total number of daily hours that could be reported, we 
have decided to simply leave the cap at 24 hours. This 
was because we have spoken to many carers who claim 
that they and, if it is the case, the additional carers do 
more than just a nine-to-five job when it comes to their 
responsibilities towards the patient. 
6. Comparability of results
In order to ensure the comparability of costs estimated 
in our study with the international estimates published in 
different national currency units and for different years, 
we have converted the results to 2013 international dol-
lars (I$). 
To convert published data on costs of dementia to 
2013 values (the year of costs data in our study) the GDP 
deflators approach was applied. GDP deflator series pro-
vide indicators of growth in price level for entire econo-
mies.
The GDP deflator accounts for inflation by convert-
ing output measured at current prices into constant-dol-
lar GDP. The GDP deflator shows how much a change 
in the base year’s GDP relies upon changes in the price 
level. The GDP deflator has an advantage over the Con-
sumer Price Indexes (CPI) because it is not based on 
a fixed basket of goods and services. The method is 
summarised in Box 1.
Results
1. Participants’ characteristics
As mentioned above, there were, in total, 31 partici-
pants, all carers of a patients with dementia. For further 
participant characteristics please consult Table II. We 
have noticed a slight predominance of moderate cases of 
dementia, but, as has been suggested by our partner doc-
tors, most patients in Romania only obtain a diagnosis 
in the moderate to severe stages of dementia, with most 
cases currently remaining undetected.
Box 1. Steps of recalculation of published data in order to ensure comparability
Conversion is done in two steps:
Step 1: Presenting costs from publication in terms of 2013 value. To convert from costs in year A of original costs (for example 2006) in 
national currency units (NCU) to costs in year B (for year 2013) in NCU the following formula was used, incorporating national deflators for 
the corresponding years [91]:
Costs in 2013 in NCU = Costs in 2006 in NCU × 
National Deflator in 2013
National Deflator in 2006
Step 2: In converting costs in 2013 NCU to international dollars (I$) in 2013, the national currency per US dollar PPP conversion factors for 
GDP were used [92]. 
Source: Authors’ own elaboration.
Table II. Participant characteristics











• Other (grandchildren and carers)




Caregiver economic status  
• Earn an income
• Do not earn an income


















Caregiver household monthly income 
(Median, IQR)
• All participants 3,000 (1,650–4,000)
Data are n (%) unless otherwise stated.
Source: Authors’ own elaboration.
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2. Service utilisation
Of the participants 27 (87%) reported that the patient 
in their care received medication therapy for dementia. 
Of these, two thirds were taking memantine (Ebixa), 
while the remainder had been prescribed donepezil. 
With regards to inpatient care, 4 carers (12.9%) reported 
patient hospitalisation in the Internal Medicine ward, 
while only one carer reported that their patient had been 
hospitalised in an undisclosed type of ward, in the past 
year. Furthermore, 4 patients (12.9%) were reported to 
have visited a GP outpatient practice in the past 30 days, 
11 (35.5%) had visited a Geriatrician, 1 (3.2%) had vis-
ited a Neurologist, 1 (3.2%) had visited a Psychiatrist, 
1 (3.2%) had visited a Physiotherapist and 3 (9.7%) had 
visited other services not specified in the questionnaire: 
a Urologist, a Bioenergy Therapist and a Medical Nurse 
(see Table III for more information on outpatient and in-
patient visits). As can be seen in Table III, the difference 
between the service utilisation of dementia patients by se-
verity of disease groups was statistically significant only 
in outpatient services and when all study subjects were 
considered (p = 0.017). Of the total participant popula-
tion, 4 (12.9%) reported the patient’s use of emergency 
medical services in the past 90 days. Social services were 
rarely used: 4 (12.9%) had reported regular visits from 
a home aid. Only 1 (3.2%) reported patient attendance at 
a day care centre, while 2 (6.7%) reported regular visits 
from a medical nurse. Services such as visits by social 
assistants and food delivery were not used by anyone in 
our sample. 
3. Costs
The present study evaluated the Cost-of-Illness of 
dementia in Romania from a societal perspective, al-
though we did not include in our final analysis losses 
due to mortality or the carer’s health-related expenses. 
The mean total (direct and indirect) costs of dementia 
using different units for valuing time lost due to caring 
were: a) 67,554.3 RON (I$40,583.3 in 2013 international 
dollars) per patient when an average hourly wage of 
10 RON per hour was used for estimating the indirect 
costs; b) 55,712 RON (I$33,469) when an hourly carer 
wages of 5.75 RON was employed and c) 53,787 RON 
(I$32,312.6) when the minimum wage of 5.06 RON was 
used. The total annual cost of dementia in Romania using 
these assumptions was: a) 18.24 bln RON (I$10.96 bln), 
b) 15,04 bln RON (I$9.04 bln), and c) 14,52 bln RON 
(I$8.72 bln) based on the unofficial estimate of about 
270,000 people suffering from dementia, the [81] and 
based on figures produced by Alzheimer Europe [93]. 
The unit costs used to estimate direct and indirect costs 
are presented in Table IV.
The annual total direct costs extrapolated to the 
entire population suffering from dementia in Romania 
amounted to 9.3 bln RON (I$5.6 bln) (with on aver-
age, an annual direct cost per patient of approximately 
34,362 RON, I$20,643). Table V presents the break-
down of direct costs by the severity of the disease. The 
mean direct medical costs accounted for 11,132.3 RON 
(I$6,687.74) (Table V). Over 51% of these are incurred 
by patients and their families (Figure 1). Figure 2 pre-
Table III. Annual number of medical services used per person with dementia by disease severity.
Study subjects who reported using the service p value All study subjects p value
n (%) mean (SD) N mean (SD)
Hospital admissions
All patients 12 (38.7%) 1.08 (0.29) 31 0.42 (0.56)
Mild 1 (11.1%) 2.00
0.145
9 0.22 (0.66)
0.422Moderate 6 (42.9%) 1.00 (0) 14 0.43 (0.51)
Severe 5 (62.5%) 1.00 (0) 8 0.63 (0.52)
Days of hospitalisation per person
All patients 12 (38.7%) 17.08 (13.84) 31 6.61 (11.91)
Mild 1 (11.1%) 55
0.276
9 6.11 (18.33)
0.217Moderate 6 (42.9%) 15.83 (7.99) 14 6.79 (9.52)
Severe 5 (62.5%) 11.00 (6.24) 8 6.88 (7.40)
Outpatient visits
All 15 (48.4%) 71.2  (149.16) 31 34.45 (108.12)
Mild 8 (88.9%) 66.00 (143.14)
0.171
9 58.67 (135.69)
0.017Moderate 3 (21.4%) 164.00 (252.95) 14 35.14 (121.33)
Severe 4  (50.0%) 12.00 (0) 8 6.00 (6.41)
n = number of respondents reporting use of service; N = number of respondents in the study group
p values reported for differences in service use between the disease severity of patients groups 
Source: Authors’ own calculations.
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Table IV. Unit costs
Service Cost (RON)
Dementia diagnostic tests 247.9
Cost of one visit to the emergency service 125
Cost of one GP consultation 9.9
Cost of one Geriatric consultation 25.9
Cost of one Neurologist consultation 58.3
Cost of one Physiotherapist consultation1 19.4
Cost of one Occupational Therapist consultation 19.4
Cost of one Social Worker consultation 19.4
Cost of one Psychologist consultation 19.4
Cost of consultations by other specialists 19.4
Cost of inpatient stay in the Internal Medicine ward 915
Cost of inpatient stay in the Geriatric ward 171.1
Cost of inpatient stay in the Psychiatric ward2 198.3
Cost of inpatient stay in the Surgery ward 198.3
Cost of inpatient stay in the General Medicine Ward 198.3
Cost of inpatient stay in other wards 198.3
Transportation As indicated by the patient. If costs were not provided, we assumed a return trip 
using public transportation services, with a one-way ticket cost of 1.3 RON
Social services As indicated by patients
Indirect costs of caregiving
• Using average national wage
• Using caregiver hourly wage




1 Due to lack of data for these services, a default value was used for the costs of consultations by Physiotherapist, Occupational Therapist, Social 
Worker, Psychologist and other specialisms.
2 Due to lack of data we similarly used a default rate for the following services: Psychiatric, Surgery, General Medicine and other wards. 
Source: Authors’ own elaboration.
Table V. Direct costs (medical and non-medical) per patient in the study by illness severity
Cost categories
Mild (n = 9)
Mean RON
(SD)
Moderate (n = 14)
Mean RON
(SD)
Severe (n = 8) 
Mean RON
(SD)





























































































Source: Authors’ own elaboration.
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sents the proportion of direct medical costs incurred by 
different payers.
The total extrapolated to the entire population indirect 
costs varied, according to the different hourly wages used 
for valuing caregiving time between: a) 8,96 bln RON 
(I$5.38 bln); b) 5.76 bln RON (I$3.46 bln) and c) 5.24 bln 
RON (I$3.15 bln), equating to individual average an-
nual costs of: a) 33,192.8 RON (I$19,940.6); b) 21,350.6 
RON (I$12,826.39) and c) 19,425.9 RON (I$11,670.13) 
respectively. See Tables VI to VIII for further informa-
tion on the indirect costs by type of disease severity. 
The first category of the estimated indirect cost per 
person with dementia from the study contains value of 
time spent caregiving by carers of both productive and 
retirement age. The time that retired caregivers dedicated 
to caring after people with dementia was valued at the 
minimum hourly wage in Romania in 2013. This, on av-
erage, accounted for 7,972 RON (25%, 40% and 44% of 
the totals presented for this category in Tables VI, VII 
and VIII respectively).
Discussion
In this cost-of-illness study, with a mix of top-down 
and bottom-up approaches for collecting data, the so-
cietal cost of dementia was investigated. Based on the 
World Bank, World Development Indicators PPP con-
version factor for GDP (LCU per international $) in the 
year 2013 [92], our calculations place the total cost of 
dementia in Romania between I$10.96 and I$8.72 bln 
2013 international dollars. The latest statistical report we 
could find shows that total healthcare expenses reached 
31.2 bln RON in 2011 [94] which, after converting it to 
its 2013 value in RON (following step one of the method 
presented in Box 1), amounts to 33.8 bln RON. This 
means that the total direct medical cost of dementia (of 
3.0 bln RON for all 270,000 people with dementia in Ro-
mania) calculated in the study represents approximately 
8.9% of the total annual health spending. Our estimate 
differs considerably (representing a value which is five 
to seven times higher) from the previous estimate of the 
Figure 1. Proportion of average direct medical costs paid by 




Source: Authors’ own elaboration.
Figure 2. Proportion of direct medical costs by type of service and source of payment



















Inpatient services Medicines and diagnostic services
Source: Authors’ own elaboration. 
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cost of dementia in Romania which was compiled by 
Alzheimer Europe [95]. The authors of this research, 
Wimo and colleagues, estimated the total costs of demen-
tia in Romania at 605.4 mln Euros, with a breakdown 
of 270.5 mln for direct and 334.9 mln for indirect costs 
[95]. We have converted these estimates to 2013 interna-
tional dollars using the official exchange rate of RON to 
EUR in 2008 and the GDP deflators for 2008 and 2013 
to present these costs in terms of NCU (RON) in the year 
2013. After applying the procedure presented in Box 1 
the estimates by Wimo and colleagues [95] for the total 
cost of dementia in Romania in 2013 accounted for over 
I$1.67 bln (I$0.75 bln direct costs and I$0.93 bln indirect 
costs). It is likely that the estimated number of dementia 
sufferers was lower in 2008 than in 2013. The difference 
is probably also because of our choice to take into ac-
count more than 8 hours per day of work when it comes 
to calculating the costs of care. 
Our results showed that direct costs outweigh indirect 
costs, which is contrary to theoretical expectations about 
the regional cost structure [95]. It should be recognised 
that this may be due to certain cost dimensions being 
excluded from our analysis, such as mortality costs, or 
morbidity costs associated with a carer’s illness, which 
would have normally been added to the total indirect cost 
figure. The situation in Romania regarding caregiving is 
different from most Western countries and is more simi-
lar to the way patients are treated in Mediterranean Eu-
rope. Thus, the use of care homes is relatively rare, with 
most patients being cared for by a relative (usually their 
Table VI.  Indirect costs per patient, by illness severity (using average national wage)
Cost categories Mild (n = 9)Mean RON (SD)
Moderate (n = 14) 
Mean RON (SD)
Severe (n = 8) 
Mean RON (SD)
Total (n = 31)
Mean RON (SD)
Yearly indirect cost of caregiving for patient 
(using the average national hourly wage) 23,482.3 (24,508.8) 31,646.4 (31,087.9) 41,614.8 (23,258.8) 31,848.7 (27,416.4)
Cost of patient time lost accessing medical care 1,153.5 (2,110.4) 923.6 (1,994.1) 384.5 (304.8) 851.2 (1,737.9)
Cost of unemployment or permanent reduction 
of work time due to caring responsibilities 0 774.3 (1744) 555 (1,472.2) 492.9 (1,391.6)
Total indirect costs 24,635.8 (24,494.4) 33,355.3 (31,335) 42,554.2 (23,250.6) 33,192.8 (27,512.9)
Source: Authors’ own elaboration. 
Table VII. Indirect costs per patient, by illness severity (using caregiver wage)
Cost categories Mild (n = 9)Mean RON (SD)
Moderate (n = 14)
Mean RON (SD)
Severe (n = 8) 
Mean RON (SD)
Total (n = 31)
Mean RON (SD)
Annual  indirect cost of caring for patient (using 
the carer’s  hourly wage) 16,096.4 (12,806.5) 19,972.3 (17,477.8) 24,465.1 (12,605.7) 20,006.4 (14,935.6)
Cost of patient time lost accessing medical care 1,153.5 (2,110.4) 923.6 (1,994.1) 384.5 (304.8) 851.2 (1,737.9)
Cost of unemployment or permanent  
reduction of work time due to caring  
responsibilities
0 774.3 (1,744) 555 (1,472.2) 492.9 (1,391.6)
Total indirect costs 17,249.8 (12,716.5) 21,670.2 (17,709.1) 25,404.6 (12,595.1) 21,350.6 (15,017)
Source: Authors’ own elaboration.
Table VIII. Indirect costs per patient, by illness severity (using minimum wage)
Cost categories Mild (n = 9)Mean RON (SD)
Moderate (n = 14) 
Mean RON (SD)
Severe (n = 8) 
Mean RON (SD)
Total (n = 31)
Mean RON (SD)
Annual  indirect cost of caring for patient  
(using the national minimal wage) 14,895.9 (10,976) 18,075 (15,398.3) 21,677.8 (10,900.3) 18,081.8 (13,003.5)
Cost of patient time lost accessing medical care 1,153.5 (2,110.4) 923.6 (1,994.1) 384.5 (304.8) 851.2 (1,737.9)
Cost of unemployment or permanent reduction 
of work time due to caring responsibilities 0 774.3 (1744) 555 (1,472.2) 492.9 (1391.6)
Total indirect cost 16,049.4 (10,859) 19,772.9 (15,622.5) 22,617.3 (10,888.8) 19,425.9 (13,079.1)
Source: Authors’ own elaboration. 
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spouse or child). It has been suggested that this attitude 
reflects deeply held values and social norms, which are to 
a great extent, shaped by religious beliefs as well. Indeed, 
religion is an important aspect of social life in Romania, 
where the predominant religion is Christian Orthodoxy, 
with approximately 86% of the total population declar-
ing their adherence to this denomination [96]. Like other 
Christian denominations, it considers caring (including 
care for elderly dependents) a key duty for its follow-
ers. The Church dedicated 2012 to the promotion of care 
for the sick [97]. Additionally, there is also a growing 
number of home care programmes delivered nationally 
by Catholic organisations.
The higher costs generally recorded for Eastern Euro-
pean countries, as compared to Western countries, can be 
explained by the better medical and social infrastructure 
present in the West. Nevertheless, we can also speculate 
that inter-generational relations differ between these cul-
tures, as influenced by the economic behaviour of the 
“baby-boomers” and the increasing general burden felt 
by the younger generations. This is something that was 
outlined by de Hennezel and Hennezel [98] in a socio-
psychological study of French people aged 35 to 45, who 
often stated that they did not feel responsible for the care 
of their parents as they aged, giving as reasons, the eco-
nomic excesses indulged in by the latter and the lack of 
support received by the former. It may be that the differ-
ent political and economic realities which were present 
in communist Romania have encouraged relationships 
based on solidarity and mutual help.
In the Results section, we have distinguished the di-
rect costs covered out-of-pocket by patients and those 
reimbursed by the public payer (i.e. the NHIH). It should 
be noted that, in some instances, the individual costs were 
much higher than expected, which is probably due to 
incomplete questionnaires being returned. For instance, 
the medication and diagnosis costs were covered, accord-
ing to our calculations, only to a level of 38.85% by the 
NHIH, leaving the yearly out-of-pocket payment of indi-
viduals as 5,027 RON (I$3,020) for this expense alone. 
It is likely that this is an overestimate of out-of-pocket 
costs, since many participants did not indicate to what 
extent the medication cost of the patient in their care was 
covered by the public payer and, in such cases, we used 
the default rates present in the official NHIH database. 
However, it is likely that many of the participants were 
beneficiaries of special reimbursement schemes (e.g. the 
full reimbursement of dementia drugs). Most of the other 
medical costs (inpatient and outpatient) are generally 
covered by the public purse, although it should be noted 
that usually hospitals do not provide discounted essential 
services and products, such as food, disposable diapers or 
products for skin treatment, especially those used in the 
treatment of bed sores.
It is likely that our figures for transportation costs are 
an underestimate, since participants very rarely provided 
the necessary information about the costs involved. As 
a result, a return journey using public transport services 
was assumed, using the cost of a bus ticket in Bucharest 
(1.3 RON) for a one-way journey. Additionally, we used 
the online pharmacy price for medicines not included in 
the official database provided by the NHIH and we as-
sumed this indicated that the cost of the particular drugs 
were not covered by the public payer. In this way, the 
final figure for medication use is also probably slightly 
underestimated. It should also be mentioned that our 
“yearly” estimates contain a year made up of 360 days, 
due to the use of 30 days as a proxy for 1 month when 
calculating total costs.
Our results seem to confirm that costs for dementia 
peak towards the severe and final stage, when medi-
cal costs rise and, especially, the time spent caring for 
patient approaches a maximum. Carers also seem more 
likely to give up on their working hours in order to care 
for patients in the later stages of dementia (moderate and 
severe), while no such incident was recorded in the case 
of patients with mild dementia. The use of non-medical 
social services is not common for the studied population 
sample, which may reflect a more typical tendency in the 
Romanian population and the poor development of so-
cial services, when compared to Western countries. Even 
when provided, social services in Romania (such as daily 
caring, or food delivery) are more likely to be provided 
by an informal caregiver, for an unofficial wage, which 
also explains why we were unable to obtain an official es-
timate of a carer’s wage. Even official websites, intended 
to connect patients to potential carers do not indicate the 
cost, stating that they are to be negotiated on an indi-
vidual basis with the particular carer.
Finally, our results underestimate the average direct 
medical costs. In order to reduce the length of interviews 
we did not ask about the impact of caregiving on the car-
er’s health (and in consequence did not include the costs 
of health care services used by carers). This is a crucial 
issue and needs to be a subject of further research to elicit 
what the impact of care for dementia patients on Health 
Related Quality of Life is and what the costs of health 
care services used by caregivers are, attributable to the 
care for dementia patients.
The trend in developed countries has shifted mas-
sively towards issues such as early detection of the signs 
and prevention of dementia (see [99] for an example of 
a more recent national strategy regarding dementia). The 
aim is to identify future patients early, using intermedi-
ary, non-clinical stages such as the MCI, which was re-
ferred to in the section on early diagnosis, and to focus 
on educating the public as well as professionals. Further-
more, mixed teams are proposed in order to deal with 
the various challenges of dementia in a wide range of 
settings, and not only the medical. In Romania, however, 
there still is a struggle to diagnose more patients in the 
mild stage, since most are usually diagnosed only in the 
moderate to severe stage. The level of public awareness 
is still low, albeit improving, with most patients being 
taken to a specialist by their families when they start get-
ting lost more frequently, or when they display serious 
behavioural disturbances. Relatives are not worried as 
much about the fact that patients become confused and/
or more forgetful, which reveals an important deficit in 
knowledge about the signs and symptoms of dementia. 
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However, as mentioned in the introduction, it is clear that 
most Romanians would not downplay the significance of 
the diagnosis of dementia. 
The investments made by Western European coun-
tries; such as the UK, France and Switzerland, in funding 
awareness campaigns, supporting primary care, detec-
tion of early cases and in building new medical facili-
ties, dedicated to patients with dementia, have reached 
a considerable level in recent years. A good instance of 
this latter point is the special ward recently constructed 
at the Cefn Coed Hospital in Swansea, which features ar-
chitecture specially designed for patients’ needs, includ-
ing sensory stimulating chambers, a quiet garden, easy to 
navigate and colour-based marks that help the patient to 
move easily within the hospital bounds. The amount of 
investments made by the Romanian government, howev-
er, has been minimal, and the physical space dedicated to 
ambulatory care of dementia patients is also scarce and, 
many a time, self-sustained (as is the case with the centre 
run by the RAS or the Ana Aslan centre). It is fair to say 
that, Romanians probably use social and medical services 
much more infrequently than their Western counterparts. 
In itself, this may in fact be a positive aspect, since many 
care improvement programmes developed recently stress 
that it is important that hospitalization and/or institu-
tionalisation are avoided and focus instead on improv-
ing home care [100]. Governments may also use this as 
a cost-controlling strategy. However, there is a real need 
for political commitment to the cause of dementia in Ro-
mania, which has been largely ignored to date.
We have given some of the limitations of the present 
study: the small sample size, the exclusion of certain 
cost categories, due to logistic difficulties (such as the 
indirect costs due to deaths and carer’s medical care ser-
vices costs), or the gaps in carer’s response to different 
questions or sections in the questionnaire. This led us to 
use alternative, default values, where this was possible. 
Furthermore, we should indicate that we have probably 
overestimated the figures when calculating the indirect 
costs of caring for patients. A better estimate would need 
to take into account the national unemployment rate, 
which was not considered in the present analysis. 
The final point is that the study was mainly a pilot 
project aiming to test the feasibility of the study tool 
(the modified RUD questionnaire); an attempt to show 
the significance of dementia costs in Romania and to 
find some key areas for further investigation and ac-
tion. From what we have determined so far, there is 
a real need for better and targeted carer support, since 
the indirect costs of caring (the value of production lost 
by carers looking after the patients) constitute between 
a third and a half of the total costs of dementia in Ro-
mania. The state should also value the role of carers in 
offering costly services that would otherwise need to 
be covered by a mix of social and medical insurance, 
as well as by individuals themselves. Finally, the state 
should take more into account that “the family and 
friends of the person with dementia, are in all regions 
of the world, the cornerstone of the system of care and 
support” [14, p. 46].
Note
1  We define effective economic old-age dependency ratio as 
the percentage of the employed population aged between 15 to 
64 represent out of the inactive population aged 65 and above.
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Appendix: The modified RUD questionnaire that was used in our reserch with variables’ coding displayed
The resource utilization in dementia (RUD) questionnaire
A1. Caregiver
A1.1. Description of Primary Caregiver









5. Other                                                         □
        (Staff not allowed)
4. NoCh: Number of children currently living with you:
                       child(ren)




6. LWP: Do you live together with the patient? If your 
answer is Yes, then please skip to question number 9.
1. Yes □
2. No □
7. DIST: How far do you live from the place where the 
patient currently resides?
                                          (preferrably in kilometres)
8. TTP: How do you access the patient’s residence from 
your home?
a. By walking □
b. By bicycle □
c. By scooter/motorcycle □
d. By private car □
e. By public transportation □
f. By taxi □
g. Other                                                          □
9. NoCa: How many other caregivers are involved in car-





• 4 or more □
10. CON: Among all caregivers what is your level of 
contribution? Please note that 100% = the total car-













• 6 or more □
12. MI: Please state your household income per month:
      _______________________ RON
A1.2. Caregiver Time
1. LEEP: On a typical care day during the last 30 days, 
how much time per day and night did you spend 
asleep?
     _________ hours and ____________ minutes per day
2. a) PADL1: On a typical care day during the last 30 
days, how much time per day did you assist the pa-
tient with tasks such as toilet visits, eating, dressing, 
grooming, walking and bathing?
    ___________ hours and ___________ minutes per day
2. b) PADL2: During the last 30 days, how many days 
did you spend providing these services to the patient
    __________ hours and ____________ minutes per day
3. a) IADL1: On a typical care day during the last 30 
days, how much time per day did you assist the patient 
with tasks such as shopping, food preparation, house-
keeping, laundry, transportation (including hospital 
and visits), taking medication and managing financial 
matters?
    __________ hours and ____________ minutes per day
3. b) IADL2: During the last 30 days, how many days 
did you spend providing these services to the patient?
    ____________ days
4. a) SUP1: On a typical care day during the last 30 days, 
how much time per day did you spend supervising 
(that is, prevent dangerous events) the patient?
    ___________hours and ____________minutes per day
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4. b) SUP2: During the last 30 days, how many days did 
you spend providing these services to the patient?
    ____________ days
A1.3. Caregiver Work Status
1. INC: Do you currently work for pay from any sources 
(including caregiving)?
1. Yes □ If yes, please answer questions 3 to 5
2. No □ If no, please answer question 2 
2. WSW: Why did you stop/reduce working?
1. Never worked □
2. Reached retirement age □
3. Early retirement (not disease-related) □
4. Laid off □
5. Own health problems □
6. To care for patient □
7. Other ___________________________ □
3. NoHPW: How many hours per week do you work for 
pay in total?
 __________ hours per week                        □ None
4. NoDPC: Of this number of hours, how many hours per 
week are you paid to care for the patient?
___________ hours per week                       □ None
5. WHR: During the last 30 days, by how many hours 
have you cut down on the number of hours that you 
usually work each week because of your caregiving 
responsibilities?
__________ hours per week                         □ None
6. During the last 30 days, please specify the number of 
times that your caregiver responsibilities have affected 
your work in the following ways:
A. Missed a whole day of work
ICRA1: ___________ number of times     □ None
B. Missed a part of a day of work
ICRA2: ___________ number of times     □ None
A2. PATIENT
A2.1. Patient Living Accommodation
1. CPA: Please specify the patient’s current living accom-
modation
1. Own home (owner occupied or rented) □
2. Intermediate forms of accommodation 
    (not dementia-specific) □
3. Dementia-specific residential accommodation □
4. Long-term institutional care □
5. Other ______________________________ □






6. Not applicable ______________________ □
3. AAc: During the last 30 days, if the patient temporarily 
changed living accommodations (i.e. moved to a new 
location for more than 24 hours and then back to the 
original location), please specify the number of nights 
spent in this temporary living accommodation.
1. Own home (owner occupied or rented) □
2. Intermediate forms of accommodation 
    (not dementia-specific) □
3. Dementia-specific residential accommodation □
4. Long-term institutional care  □ 
5. Other _______________________________ □
A2.2. Patient Health Care Resource Utilization
1. NoR: During the last year, how many times was the patient referred to a hospital (for more than 24 hours)? If your 
answer is None, please go to question 6.
___________ number of times □ None 
2. HAR: Was the patient admitted to a hospital each time he/she was referred by a specialist? If your answer is Yes, 
please go to question 4.
• Yes □
• No □
3. RNH: Can you specify for what reason the patient was not admitted to a hospital?
1. Financial reasons □
2. Long waiting time □
3. Would have taken too long to go there/too far away □
4. Lack of means of transport □
5. Other (please specify) □ __________
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Out-of-pocket payment for entire stay 
in the ward. This may include costs 
of medical services and medicine not 
covered by the insurance during the 
stay in the hospital
Please estimate additional expenses 
not related to medical costs (e.g. food, 
disposale diapers, waterproof sheds etc.)
Geriatric G_NoN G_TrC G_OOPP G_AdE
Psychiatric P_NoN P_TrC P_OOPP P_AdE
Internal 
medicine
IM_NoN IM_TrC IM_OOPP IM_AdE
Surgery Sg_NoN Sg_TrC Sg_OOPP Sg_AdE
Neurology N_NoN N_TrC N_OOPP N_AdE
General ward GW_NoN GW_TrC GW_OOPP GW_AdE
Other (please 
specify)
O_NoN O_TrC O_OOPP O_AdE
5. Hosp_Pu_Pr: Was the patient admitted into a private or a public ward?
• Public □
• Private □
6. During the last 30 days, consider how many times the patient has visited a doctor, physiotherapist, psychologist or 
other health care professional. Please specify the number of visits for each type of care received.□ The patient did not visit any of these health care professionals during the last 30 days
Number of visits during  
last 30 days
Out-of-pocket payments for all visits 
(by type of care)
Transportation costs in average 
per visit (one way)
General practitioner V_GPN V_GPC V_GPTC
Geriatrician V_GN V_GC V_GTC
Neurologist V_NN V_NC V_NTC
Psychiatrist V_PtN V_PtC V_PtTC
Physiotherapist V_PhN V_PhC V_PhTC
Occupational therapist V_OTN V_OTC V_OTTC
Social worker V_SWN V_SWC V_SWTC
Psychologist V_PsN V_PsC V_PsTC
Other (e.g. specialist; please 
specify)
V_ON V_OC V_OTC
7. V_PuPr: Was the patient seen in public or private practice?
• Public □
• Private □
8. CER_90days: During the last 90 days, how many times did the patient receive care in a hospital emergency room 
(for less than 24 hours)?
 ___________ number of times  □  None
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9. For each service listed below, please specify the number of times the service was received during the last 30 days 
and the average number of hours per visit.
 □ The patient did not receive anny of these services during the last 30 days
Number of visits during  
the last 30 days
Number of hours per visit How much did the patient pay 
for these services, on average per 
visit, during the last 30 days?
Social assistant S_SAV S_SAH S_SAVC
Home aid/orderly S_HAV S_HAH S_HAVC
Food delivery S_FDV N/A S_FDVC
Day care S_DCV N/A S_DCVC
Transportation (care related) S_CTV S_CTH S_CTVC
Other (please specify) S_OV S_OH S_OVC
10. Please specify what medication the patient is currently taking (please include both prescription-based as well as 
over-the-counter medicines).






of times  
per day taken
Number of days 
taken in the last 
30 days
Was the payment 
for the medicine 
compensated by the 
insurance?
How much did you 
pay the last time you 
bought this medicine 
out-of-pocket?
How many pills or other 
units of medicine did 
you get?
1_N 1_S 1_TPD 1_DT 1_C 1_LAP 1_UNITS
2_N 2_S 2_TPD 2_DT 2_C 2_LAP 2_UNITS
3_N 3_S 3_TPD 3_DT 3_C 3_LAP 3_UNITS
4_N 4_S 4_TPD 4_DT 4_C 4_LAP 4_UNITS
5_N 5_S 5_TPD 5_DT 5_C 5_LAP 5_UNITS
6_N 6_S 6_TPD 6_DT 6_C 6_LAP 6_UNITS
